Last 12 months
Inside the activity.
0 purchase rows · 204 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 17 |
| Dec 2025 | 0 | 26 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 32 |
| Jul 2026 | 0 | 64 |
| Aug 2026 | 0 | 27 |
| Sep 2026 | 0 | 20 |
| Oct 2026 | 0 | 5 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 05, 2019 Filed Jun 7, 2019 20:17 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
GrantShare Option (Right to Buy) · Derivative | 747,708 | $0.00 Strike: $9.23 | $0.00 |
DisclosureSEC source: 0001651308-19-000060 · wf-form4_155993861664334.xml · derivative · entry 1 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 747,708 Underlying: Ordinary Shares · 747,708 shares Expires 2029-06-04 F1 · derivative.exercise_price: The number of securities underlying the option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. F1 · shares: The number of securities underlying the option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. F2 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on June 5, 2020, and the remaining in 36 successive equal monthly installments, subject to continued service. F1 · derivative.underlying_shares: The number of securities underlying the option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. F1 · balance_after: The number of securities underlying the option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 20:13 UTC |
Wu XiaobinPresident & GM China
|
GrantShare Option (Right to Buy) · Derivative | 797,550 | $0.00 Strike: $9.23 | $0.00 |
DisclosureSEC source: 0001651308-19-000057 · wf-form4_155993838897104.xml · derivative · entry 3 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 797,550 Underlying: Ordinary Shares · 797,550 shares Expires 2029-06-04 F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F3 · shares: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F4 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on June 5, 2020, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control. F3 · derivative.underlying_shares: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F3 · balance_after: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 20:13 UTC |
Wu XiaobinPresident & GM China
|
GrantOrdinary Shares | 433,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-19-000057 · wf-form4_155993838897104.xml · nonDerivative · entry 1 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,505,956 F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 20:15 UTC |
Liang HowardCFO & Chief Strategy Officer
|
GrantShare Option (Right to Buy) · Derivative | 558,285 | $0.00 Strike: $9.23 | $0.00 |
DisclosureSEC source: 0001651308-19-000059 · wf-form4_155993853416435.xml · derivative · entry 2 Liang Howard · CIK 0001663427 · CFO & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 558,285 Underlying: Ordinary Shares · 558,285 shares Expires 2029-06-04 F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. F3 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on June 5, 2020, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon a sale event. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 20:15 UTC |
Liang HowardCFO & Chief Strategy Officer
|
GrantOrdinary Shares | 75,855 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-19-000059 · wf-form4_155993853416435.xml · nonDerivative · entry 1 Liang Howard · CIK 0001663427 · CFO & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,193 F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon a sale event. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 20:08 UTC |
Glazer Donald W.Director
|
GrantShare Option (Right to Buy) · Derivative | 64,610 | $0.00 Strike: $9.23 | $0.00 |
DisclosureSEC source: 0001651308-19-000055 · wf-form4_155993809255577.xml · derivative · entry 1 Glazer Donald W. · CIK 0001660940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,610 Underlying: Ordinary Shares · 64,610 shares Expires 2029-06-04 F1 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. F1 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. F2 · derivative.exercise_date: The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. F1 · derivative.underlying_shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. Read SEC document |
| June 05, 2019 Filed Jun 11, 2019 12:25 UTC |
Yi QingqingDirector
|
GrantShare Option (Right to Buy) · Derivative | 64,610 | $0.00 Strike: $9.23 | $0.00 |
DisclosureSEC source: 0000902664-19-002708 · ownership.xml · derivative · entry 1 Yi Qingqing · CIK 0001662556 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,610 Underlying: Ordinary Shares · 64,610 shares Expires 2029-06-04 F1 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares ("ADSs") on the date of grant, as each ADS represents 13 ordinary shares. F1 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares ("ADSs") on the date of grant, as each ADS represents 13 ordinary shares. F2 · derivative.exercise_date: The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. F1 · derivative.underlying_shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares ("ADSs") on the date of grant, as each ADS represents 13 ordinary shares. F1 · balance_after: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares ("ADSs") on the date of grant, as each ADS represents 13 ordinary shares. Read SEC document |
| May 21, 2019 Filed May 22, 2019 23:04 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 28,600 | $0.00 Strike: $3.49 | $0.00 |
DisclosureSEC source: 0001651308-19-000048 · wf-form4_155856627544082.xml · derivative · entry 7 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 947,965 Underlying: Ordinary Shares · 28,600 shares Expires 2027-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares ("ADSs") on the date of grant, as each ADS represents 13 ordinary shares. F5 · derivative.exercise_date: The options vest over a four-year period as follows: 25% on the first anniversary of the date of grant, with the remaining shares vesting in 36 equal successive monthly installments on the last day of each month thereafter. Unvested options are subject to accelerated vesting upon certain termination events following a change in control. Read SEC document |
| May 21, 2019 Filed May 22, 2019 23:04 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 2,200 | $130.06 | $286,131.56 |
DisclosureSEC source: 0001651308-19-000048 · wf-form4_155856627544082.xml · nonDerivative · entry 5 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.00 to $130.27, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| May 21, 2019 Filed May 22, 2019 23:04 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionAmerican Depositary Shares | 2,200 | $45.31 | $99,682.00 |
DisclosureSEC source: 0001651308-19-000048 · wf-form4_155856627544082.xml · nonDerivative · entry 4 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. Read SEC document |
| May 21, 2019 Filed May 22, 2019 23:03 UTC |
Liang HowardCFO & Chief Strategy Officer
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 301,600 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0001651308-19-000047 · wf-form4_155856618554356.xml · derivative · entry 4 Liang Howard · CIK 0001663427 · CFO & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,120,000 Underlying: Ordinary Shares · 301,600 shares Expires 2025-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F5 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on July 15, 2016, and the remaining in 36 successive equal monthly installments, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon a sale event or certain termination events. Read SEC document |
| May 21, 2019 Filed May 22, 2019 23:03 UTC |
Liang HowardCFO & Chief Strategy Officer
|
SaleAmerican Depositary Shares | 23,200 | $130.21 | $3,020,860.40 |
DisclosureSEC source: 0001651308-19-000047 · wf-form4_155856618554356.xml · nonDerivative · entry 3 Liang Howard · CIK 0001663427 · CFO & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.00 to $130.79, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| May 21, 2019 Filed May 22, 2019 23:03 UTC |
Liang HowardCFO & Chief Strategy Officer
|
Exercise / conversionAmerican Depositary Shares | 23,200 | $6.50 | $150,800.00 |
DisclosureSEC source: 0001651308-19-000047 · wf-form4_155856618554356.xml · nonDerivative · entry 2 Liang Howard · CIK 0001663427 · CFO & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. Read SEC document |
| May 20, 2019 Filed May 22, 2019 23:04 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 3,900 | $0.00 Strike: $3.49 | $0.00 |
DisclosureSEC source: 0001651308-19-000048 · wf-form4_155856627544082.xml · derivative · entry 6 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 976,565 Underlying: Ordinary Shares · 3,900 shares Expires 2027-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares ("ADSs") on the date of grant, as each ADS represents 13 ordinary shares. F5 · derivative.exercise_date: The options vest over a four-year period as follows: 25% on the first anniversary of the date of grant, with the remaining shares vesting in 36 equal successive monthly installments on the last day of each month thereafter. Unvested options are subject to accelerated vesting upon certain termination events following a change in control. Read SEC document |
| May 20, 2019 Filed May 22, 2019 23:04 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 300 | $130.12 | $39,036.00 |
DisclosureSEC source: 0001651308-19-000048 · wf-form4_155856627544082.xml · nonDerivative · entry 3 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| May 20, 2019 Filed May 22, 2019 23:04 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionAmerican Depositary Shares | 300 | $45.31 | $13,593.00 |
DisclosureSEC source: 0001651308-19-000048 · wf-form4_155856627544082.xml · nonDerivative · entry 2 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. Read SEC document |
| May 13, 2019 Filed May 15, 2019 19:59 UTC |
Glazer Donald W.Director
|
SaleAmerican Depositary Shares | 15,027 | $125.11 | $1,880,027.97 |
DisclosureSEC source: 0001651308-19-000046 · wf-form4_155795038114805.xml · nonDerivative · entry 2 Glazer Donald W. · CIK 0001660940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.00 to $125.63, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| May 06, 2019 Filed May 8, 2019 21:53 UTC |
Liang HowardCFO & Chief Strategy Officer
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 23,400 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0001651308-19-000038 · wf-form4_155735241187265.xml · derivative · entry 4 Liang Howard · CIK 0001663427 · CFO & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,421,600 Underlying: Ordinary Shares · 23,400 shares Expires 2025-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F5 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on July 15, 2016, and the remaining in 36 successive equal monthly installments, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon a sale event or certain termination events. Read SEC document |
| May 06, 2019 Filed May 8, 2019 21:53 UTC |
Liang HowardCFO & Chief Strategy Officer
|
SaleAmerican Depositary Shares | 1,800 | $130.01 | $234,014.04 |
DisclosureSEC source: 0001651308-19-000038 · wf-form4_155735241187265.xml · nonDerivative · entry 3 Liang Howard · CIK 0001663427 · CFO & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.00 to $130.0550, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| May 06, 2019 Filed May 8, 2019 21:53 UTC |
Liang HowardCFO & Chief Strategy Officer
|
Exercise / conversionAmerican Depositary Shares | 1,800 | $6.50 | $11,700.00 |
DisclosureSEC source: 0001651308-19-000038 · wf-form4_155735241187265.xml · nonDerivative · entry 2 Liang Howard · CIK 0001663427 · CFO & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. Read SEC document |
| May 01, 2019 Filed May 2, 2019 20:07 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 51 | $126.54 | $6,453.60 |
DisclosureSEC source: 0001651308-19-000036 · wf-form4_155682762782663.xml · nonDerivative · entry 8 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F5 · security: Each American Depositary Share represents 13 Ordinary Shares F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to cover tax withholdings in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.44 to $126.56, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| May 01, 2019 Filed May 2, 2019 20:07 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 1,371 | $125.53 | $172,100.81 |
DisclosureSEC source: 0001651308-19-000036 · wf-form4_155682762782663.xml · nonDerivative · entry 7 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51 F5 · security: Each American Depositary Share represents 13 Ordinary Shares F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to cover tax withholdings in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.25 to $126.21, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| May 01, 2019 Filed May 2, 2019 20:07 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 1,402 | $124.79 | $174,950.11 |
DisclosureSEC source: 0001651308-19-000036 · wf-form4_155682762782663.xml · nonDerivative · entry 6 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,422 F5 · security: Each American Depositary Share represents 13 Ordinary Shares F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to cover tax withholdings in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.19 to $125.04, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| May 01, 2019 Filed May 2, 2019 20:08 UTC |
Wu XiaobinPresident & GM China
|
SaleAmerican Depositary Shares | 113 | $125.55 | $14,187.07 |
DisclosureSEC source: 0001651308-19-000037 · wf-form4_155682771482970.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,365 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.39 to $125.57, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| May 01, 2019 Filed May 2, 2019 20:08 UTC |
Wu XiaobinPresident & GM China
|
SaleAmerican Depositary Shares | 5,657 | $124.47 | $704,153.38 |
DisclosureSEC source: 0001651308-19-000037 · wf-form4_155682771482970.xml · nonDerivative · entry 3 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,478 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.19 to $125.04, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| May 01, 2019 Filed May 2, 2019 20:08 UTC |
Wu XiaobinPresident & GM China
|
SaleAmerican Depositary Shares | 185 | $125.43 | $23,205.18 |
DisclosureSEC source: 0001651308-19-000037 · wf-form4_155682771482970.xml · nonDerivative · entry 2 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,135 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 22:41 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 183,690 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001651308-19-000035 · wf-form4_155493609515345.xml · derivative · entry 9 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,111,465 Underlying: Ordinary Shares · 183,690 shares Expires 2026-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our ADSs on the date of grant, as each ADS represents 13 ordinary shares. F10 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of September 2, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 22:41 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 147 | $145.94 | $21,453.17 |
DisclosureSEC source: 0001651308-19-000035 · wf-form4_155493609515345.xml · nonDerivative · entry 8 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.67 to $146.04, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 22:41 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 1,281 | $144.90 | $185,617.41 |
DisclosureSEC source: 0001651308-19-000035 · wf-form4_155493609515345.xml · nonDerivative · entry 7 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147 F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.49 to $145.15, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 22:41 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 2,304 | $143.72 | $331,132.49 |
DisclosureSEC source: 0001651308-19-000035 · wf-form4_155493609515345.xml · nonDerivative · entry 6 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,428 F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.32 to $144.24, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 22:41 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 6,159 | $142.73 | $879,059.90 |
DisclosureSEC source: 0001651308-19-000035 · wf-form4_155493609515345.xml · nonDerivative · entry 5 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,732 F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.32 to $143.25, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 22:41 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 3,439 | $141.80 | $487,661.55 |
DisclosureSEC source: 0001651308-19-000035 · wf-form4_155493609515345.xml · nonDerivative · entry 4 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,891 F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.30 to $142.27, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 22:41 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 800 | $140.49 | $112,390.00 |
DisclosureSEC source: 0001651308-19-000035 · wf-form4_155493609515345.xml · nonDerivative · entry 3 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,330 F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.10 to $141.06, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 22:41 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionAmerican Depositary Shares | 14,130 | $29.49 | $416,693.70 |
DisclosureSEC source: 0001651308-19-000035 · wf-form4_155493609515345.xml · nonDerivative · entry 2 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 22:30 UTC |
Glazer Donald W.Director
|
SaleAmerican Depositary Shares | 14,973 | $136.10 | $2,037,825.30 |
DisclosureSEC source: 0001651308-19-000027 · wf-form4_155294821804203.xml · nonDerivative · entry 2 Glazer Donald W. · CIK 0001660940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.00 to $136.88, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 20:25 UTC |
Wang XiaodongDirector
|
GiftOrdinary Shares | 2,392 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-19-000026 · wf-form4_155259511499877.xml · nonDerivative · entry 2 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,674,639 F1 · price: Bona fide gift of shares which is exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-5. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 20:25 UTC |
Wang XiaodongDirector
|
GiftOrdinary Shares | 18,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-19-000026 · wf-form4_155259511499877.xml · nonDerivative · entry 1 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,677,031 F1 · price: Bona fide gift of shares which is exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-5. Read SEC document |
| March 11, 2019 Filed Mar 11, 2019 23:38 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 33,345 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001651308-19-000025 · wf-form4_155234748424089.xml · derivative · entry 5 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,295,155 Underlying: Ordinary Shares · 33,345 shares Expires 2026-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our ADSs on the date of grant, as each ADS represents 13 ordinary shares. F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of September 2, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events. Read SEC document |
| March 11, 2019 Filed Mar 11, 2019 23:38 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 2,565 | $130.00 | $333,450.00 |
DisclosureSEC source: 0001651308-19-000025 · wf-form4_155234748424089.xml · nonDerivative · entry 4 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| March 11, 2019 Filed Mar 11, 2019 23:38 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionAmerican Depositary Shares | 2,565 | $29.49 | $75,641.85 |
DisclosureSEC source: 0001651308-19-000025 · wf-form4_155234748424089.xml · nonDerivative · entry 3 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,565 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. F4 · price: The exercise price is reflected in ADSs. Read SEC document |
| March 07, 2019 Filed Mar 11, 2019 23:38 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 71 | $140.50 | $9,975.57 |
DisclosureSEC source: 0001651308-19-000025 · wf-form4_155234748424089.xml · nonDerivative · entry 2 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · shares: These shares were acquired under the BeiGene, Ltd. Second Amended and Restated Employee Share Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| March 06, 2019 Filed Mar 6, 2019 23:32 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 100 | $150.00 | $15,000.00 |
DisclosureSEC source: 0001651308-19-000022 · wf-form4_155191513982829.xml · nonDerivative · entry 19 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 100 F1 · security: Each American Depositary Share represents 13 Ordinary Shares F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F10 · ownership.nature: These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| March 05, 2019 Filed Mar 6, 2019 23:32 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 200 | $154.92 | $30,983.00 |
DisclosureSEC source: 0001651308-19-000022 · wf-form4_155191513982829.xml · nonDerivative · entry 18 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F18 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.85 to $154.98, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. F10 · ownership.nature: These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| March 05, 2019 Filed Mar 6, 2019 23:32 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 444 | $154.08 | $68,411.25 |
DisclosureSEC source: 0001651308-19-000022 · wf-form4_155191513982829.xml · nonDerivative · entry 17 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 200 F1 · security: Each American Depositary Share represents 13 Ordinary Shares F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.55 to $154.46, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. F10 · ownership.nature: These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| March 05, 2019 Filed Mar 6, 2019 23:32 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 1,665 | $152.39 | $253,735.34 |
DisclosureSEC source: 0001651308-19-000022 · wf-form4_155191513982829.xml · nonDerivative · entry 16 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 644 F1 · security: Each American Depositary Share represents 13 Ordinary Shares F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.17 to $152.86, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. F10 · ownership.nature: These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| March 05, 2019 Filed Mar 6, 2019 23:32 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 1,921 | $151.60 | $291,233.01 |
DisclosureSEC source: 0001651308-19-000022 · wf-form4_155191513982829.xml · nonDerivative · entry 15 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,309 F1 · security: Each American Depositary Share represents 13 Ordinary Shares F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.16 to $152.15, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. F10 · ownership.nature: These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| March 05, 2019 Filed Mar 6, 2019 23:32 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 2,000 | $150.55 | $301,091.00 |
DisclosureSEC source: 0001651308-19-000022 · wf-form4_155191513982829.xml · nonDerivative · entry 14 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,230 F1 · security: Each American Depositary Share represents 13 Ordinary Shares F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.16 to $151.07, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. F10 · ownership.nature: These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| March 05, 2019 Filed Mar 6, 2019 23:32 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 600 | $154.30 | $92,581.98 |
DisclosureSEC source: 0001651308-19-000022 · wf-form4_155191513982829.xml · nonDerivative · entry 8 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.13 to $154.56, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| March 05, 2019 Filed Mar 6, 2019 23:32 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 1,958 | $152.43 | $298,464.60 |
DisclosureSEC source: 0001651308-19-000022 · wf-form4_155191513982829.xml · nonDerivative · entry 7 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 F1 · security: Each American Depositary Share represents 13 Ordinary Shares F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.11 to $152.94, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| March 05, 2019 Filed Mar 6, 2019 23:32 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 2,233 | $151.54 | $338,386.59 |
DisclosureSEC source: 0001651308-19-000022 · wf-form4_155191513982829.xml · nonDerivative · entry 6 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,558 F1 · security: Each American Depositary Share represents 13 Ordinary Shares F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.01 to $151.98, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.